AI assistant
Sending…
UNITED THERAPEUTICS Corp — Director's Dealing 2016
Jan 7, 2016
30320_dirs_2016-01-07_c8600f95-edce-46e0-8851-402ff0a68ce6.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: UNITED THERAPEUTICS Corp (UTHR)
CIK: 0001082554
Period of Report: 2016-01-06
Reporting Person: JEFFS ROGER (Director, President & Co-CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2016-01-06 | Common Stock | M | 4000 | $65.80 | Acquired | 4559 | Direct |
| 2016-01-06 | Common Stock | D | 4000 | $147.12 | Disposed | 559 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2016-01-06 | Share Tracking Award | $65.80 | M | 4000 | Disposed | 2021-03-15 | Common Stock (4000) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 19760 | Indirect |
| Common Stock | 6773 | Indirect |
Footnotes
F1: Exercise of a cash-settled share tracking award pursuant to a Rule 10b5-1 trading plan entered into by the reporting person.
F2: Shares held by a family limited liability company of which the reporting person and his spouse are managing members.
More from UNITED THERAPEUTICS Corp
Regulatory Filings
2026
Jun 2
Earnings Release
2026
May 6
Interim / Quarterly Report
2026
May 6
Annual Report
2026
Apr 29
Proxy Solicitation & Information Statement
2026
Apr 29
Regulatory Filings
2026
Mar 30
Director's Dealing
2026
Mar 27
Director's Dealing
2026
Mar 27
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 26